Physician profile
Samarthkumar Thakkar
NPI 1275185621
$9,904.49
in general payments reported to CMS, 2019-2025
19 companies · $3,096 in 2025
The $3,096 reported for 2025 was more than what 96% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $191 · 2023: $1,128 · 2024: $5,489 · 2025: $3,096.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,985 · Travel and Lodging: $1,450 · Grant: $1,014 · Education: $264.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,984.74 |
| Travel and Lodging | $1,450.30 |
| Grant | $1,014.34 |
| Education | $264.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $5,269.18 | 2023-2025 | Watchman Access System, General - Vascular Access, Avvigo Guidance System |
| Abbott Laboratories | $1,703.48 | 2024-2025 | Thoratec Heartmate 3 Lvas Implant Kit, Navitor, Perclose Prostyle |
| Medtronic, INC. | $1,238.96 | 2023-2025 | Corevalve Evolut R, Cobalt Dr Mri Surescan, Azure Xt Dr Mri Surescan |
| Amgen INC. | $394.05 | 2024-2025 | Repatha, Repatha |
| Boehringer Ingelheim Pharmaceuticals, INC. | $244.73 | 2022-2024 | Jardiance |
| Terumo Medical Corporation | $151.30 | 2024 | Tr Band, Angio-Seal |
| Kiniksa Pharmaceuticals International, Plc | $136.72 | 2024 | Arcalyst |
| Edwards Lifesciences Corporation | $120.41 | 2024 | Sapien 3 Ultra Resilia |
| Biotronik INC. | $117.34 | 2022 | |
| Philips North America LLC | $112.91 | 2024 | (Bq9) Coronary Ivus |
| Pfizer INC. | $75.90 | 2023-2025 | |
| Janssen Pharmaceuticals, INC | $63.02 | 2024 | Xarelto |
| Novartis Pharmaceuticals Corporation | $56.18 | 2024 | |
| Actelion Pharmaceuticals US, INC. | $51.49 | 2024 | Opsumit, Uptravi |
| Lantheus Medical Imaging, INC. | $47.83 | 2022-2023 | Definity |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $46.63 | 2025 | Camzyos |
| Astrazeneca Pharmaceuticals LP | $38.65 | 2023-2025 | Wainua, Andexxa |
| Bridgebio Pharma, INC. | $18.34 | 2025 | Attruby |
| Bayer Healthcare Pharmaceuticals INC. | $17.37 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Samarthkumar Thakkar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.